The NACE Clinical Highlights Show
Engage with expert NACE faculty for discussions about current clinical strategies for common and rare health conditions that you can use in clinical practice immediately, and that work for you and your patients.
It’s No Sweat… A New Approach to the Vexing Menopause VMS Challenge
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
NACE Journal Club #8
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a)
Guest:
Brad Rivotto, MD
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Â
2. Triple – Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Julio Rosenstock, MD
Senior Scientific Advisor for Velocity Clinical Research,
Director of Velocity’s site at Medical...
The APAPP Podcast Ep. 10: Idiopathic Shortness of Breath Part 2: Dysfunctional Breathing Clinic
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Cori Fratelli, RN, MSN, FNP-C
Nurse Practitioner
Division of Pul...
NACE Journal Club #7
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Long-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US Adults
Guest:
Philip Lieberman, MD,
Resident – Family Medicine Residency Program
Jefferson Health – Abington
Â
2. Association between changes in carbohydrate intake and long term weight changes: prospective cohort study
Walter C. Willett, M.D., Dr. P.H.<...
The APAPP Podcast Ep. 9: Idiopathic Shortness of Breath Part 1- Using CPET
Show Notes
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Cori Fratelli, RN, MSN, FNP-C
The NACE Journal Club with Dr. Neil Skolnik, #6
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial
Guest:
Amy Clouse, MD
Associate Director
Family Medicine Residency
Jefferson Health – Abington.
Â
2. Association Between Changes in Carbohydrate Intake and Long Term Weight Changes: Prospective Cohort Study
Guest:
Walter C. Willett, MD...
The NACE Journal Club with Dr. Neil Skolnik, #5
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial –
The New England Journal of Medicine
Guest:
Marrisa Norden, DO
Resident
Family Medicine Residency
Jefferson Health-Abington, Abington, PA
2. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation A
Randomized Clinical Trial - JAMA
Guest:<...
CME/CE Deep Dive into 5: Answering Your Questions about HoFH
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/answering-questions-about-homozygous-familial-hypercholesterolemia-9140
Featuring faculty Zahid Ahmad, MD, FNLA, and Don Wilson, MD
Summary
Homozygous familial hypercholesterolemia (FH) is a rare but critical genetic disorder characterized by extremely high LDL cholesterol levels, significantly increasing the risk of early cardiovascular disease. In this activity, Dr. Zahid Ahmad and Dr. Don Wilson provide expert insights into homozygous FH, answering questions from...
The APAPP Podcast Ep. 8: ECMO: Who are the right patients
Show Notes
NACE is excited to provide you with this podcast episode from our educational collaborator, The Association of Pulmonary Advanced Practice Providers (APAPP). APAPP is the first association of Advanced Practice Providers (APPs), both Nurse Practitioners and Physician Assistants, who work in the field of pulmonary medicine. APAPP's mission is to work together for the advancement of the profession and for the well-being of patients with pulmonary diseases. To learn more about APAPP and to get involved, please visit https://www.pulmapp.com.
Guest
Susan Wilxon, MD
 Dr...
CME/CE Podcast: Using GLP-1 RAs to Reduce CV Risk in T2D
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/using-glp-1-ras-to-reduce-cv-risk-in-t2d-9134
Summary
Type 2 diabetes (T2D) doubles a patient’s risk for atherosclerotic cardiovascular disease (ASCVD), which is the leading cause of morbidity and mortality in patients with T2D. The 2023 ADA guidelines now recommend consideration of GLP-1 RAs in patients with T2D and ASCVD or indicators of ASCVD risk, independently of A1C and metformin use. In th...
